Momenta Pharmaceuticals Inc. (MNTA) Tops Q1 EPS by 22c
Tweet
Share
E-mailGet Alerts MNTA Hot Sheet
Price: $52.48 --0%
Financial Fact:
General and administrative: 15.76M
Today's EPS Names:
FRMM, PETS, DARE, More
Financial Fact:
General and administrative: 15.76M
Today's EPS Names:
FRMM, PETS, DARE, More
Join SI Premium – FREE
Momenta Pharmaceuticals Inc. (NASDAQ: MNTA) reported Q1 EPS of $1.13, $0.22 better than the analyst estimate of $0.91, and well above Q1:10 result of a loss of $0.37. Revenue for the quarter came in at $78.2 million versus the consensus estimate of $67.12 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Aptera Motors (SEV) Reports Q2 Loss of $0.20
- Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c
Create E-mail Alert Related Categories
Earnings, Hot EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
